CMBA
ASMB icon

C.M. Bidwell & Associates’s Assembly Biosciences ASMB Stock Holding History

C.M. Bidwell & Associates’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-69
Closed -$19K – 454
2020
Q2 		$19K Buy
+69
New +$16.1K 0.02% 303

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

C.M. Bidwell & Associates's ASMB Position: Q3 2020 in Review

C.M. Bidwell & Associates sold out of Assembly Biosciences (ASMB) in Q3 2020, closing a stake of 69 shares — an estimated $19K sold.

C.M. Bidwell & Associates first reported a position in ASMB in Q2 2020 and held it in 1 quarter. The position peaked at $19K in Q2 2020. 118 funds tracked by Wall St. Rank hold ASMB as of Q3 2020.

  • C.M. Bidwell & Associates reported no remaining Assembly Biosciences position as of Q3 2020 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 69 Assembly Biosciences shares in Q3 2020, an estimated $19K.
  • C.M. Bidwell & Associates first reported a position in Assembly Biosciences in Q2 2020 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Assembly Biosciences position peaked at $19K in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2020.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.